Loading clinical trials...
Loading clinical trials...
This study hopes to determine the optimal antifibrinolytic dosing to decrease bleeding and blood transfusion after cardiac surgery without increasing adverse events
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Pennsylvania
NCT07322913 · Carotid Artery Diseases, Aortic Diseases, and more
NCT07078383 · Aortic Aneurysm, Aortic Aneurysm and Dissection, and more
NCT04005976 · Aortic Aneurysm, Aortic Dissection, and more
NCT06689839 · Aortic Stenosis Treated With TAVI, Aortic Diseases
NCT02860364 · Thoracic Aortic Disease
University of Pennsylvania
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions